Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese Patients

NCT01363193 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Obesity
Morbid Obesity
Venous Thromboembolism
Atrial Fibrillation
Angina
Chest Pain

Interventions

DRUG: Lean Body Weight-based heparin dose

Sponsor

Nazareth Hospital